AKBA

Akebia Therapeutics, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Butler John P.Director, Officer: CEO And President
$87k69.3k shares
BuyMar 4, 2026
$1.25
--
Butler John P.Director, Officer: CEO And President
$160k114.9k shares
SellFeb 2, 2026
$1.39
--
Butler John P.Director, Officer: CEO And President
$134k96.1k shares
SellFeb 2, 2026
$1.39
--
Butler John P.Director, Officer: CEO And President
$116k83.7k shares
SellFeb 2, 2026
$1.39
--
Grund NicholasChief Commercial Officer
$74k53.6k shares
SellFeb 2, 2026
$1.39
--
Butler John P.Director, Officer: CEO And President
$65k46.7k shares
SellFeb 2, 2026
$1.39
--

News

marketbeat.comAkebia Therapeutics Sees Vafseo Uptake Rising as Access and Pipeline Milestones Nearmarketbeat.comJun 4globenewswire.comAkebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.comJun 1globenewswire.comAkebia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conferenceglobenewswire.comMay 28seekingalpha.comAkebia Therapeutics, Inc. (AKBA) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 7zacks.comAkebia Therapeutics (AKBA) Reports Q1 Loss, Misses Revenue Estimateszacks.comMay 7